WEST PHARMACEUTICAL SERVICES, INC. Deferred Tax Expense from Stock Options Exercised
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Deferred Tax Expense from Stock Options Exercised of $5.50 million for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-03.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:DeferredTaxExpenseFromStockOptionsExercised · last filed 2014-11-03
- WEST PHARMACEUTICAL SERVICES, INC. deferred tax expense from stock options exercised for the quarter ending 2014-09-30 was $1.80M, a 45.45% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. deferred tax expense from stock options exercised for the quarter ending 2014-06-30 was $1.00M.
- WEST PHARMACEUTICAL SERVICES, INC. deferred tax expense from stock options exercised for the quarter ending 2014-03-31 was $2.70M, a 145.45% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. deferred tax expense from stock options exercised for the quarter ending 2013-12-31 was $3.90M, a 50.00% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. deferred tax expense from stock options exercised for fiscal 2013 was $8.30M, a 69.39% increase from fiscal 2012.
- WEST PHARMACEUTICAL SERVICES, INC. deferred tax expense from stock options exercised for fiscal 2012 was $4.90M, a 40.00% increase from fiscal 2011.
- WEST PHARMACEUTICAL SERVICES, INC. deferred tax expense from stock options exercised for fiscal 2011 was $3.50M.
| Period end | Deferred Tax Expense from Stock Options Exercised 3 month | Deferred Tax Expense from Stock Options Exercised 6 month | Deferred Tax Expense from Stock Options Exercised 9 month | Deferred Tax Expense from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2014-09-30 | $1.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-03 | $2.80M derived: sum of 2 quarters · filed 2014-11-03 | $5.50M 10-Q · filed 2014-11-03 | $9.40M derived: sum of 4 quarters · filed 2014-11-03 |
| 2014-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | $3.70M 10-Q · filed 2014-08-01 | $7.60M derived: sum of 3 quarters · filed 2014-08-01 | $10.90M derived: sum of 4 quarters · filed 2014-11-03 |
| 2014-03-31 | $2.70M 10-Q · filed 2014-05-08 | $6.60M derived: sum of 2 quarters · filed 2014-05-08 | $9.90M derived: sum of 3 quarters · filed 2014-11-03 | $9.90M derived: sum of 4 quarters · filed 2014-11-03 |
| 2013-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $7.20M derived: sum of 2 quarters · filed 2014-11-03 | $7.20M derived: sum of 3 quarters · filed 2014-11-03 | $8.30M 10-K · filed 2014-02-27 |
| 2013-09-30 | $3.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-03 | $3.30M derived: sum of 2 quarters · filed 2014-11-03 | $4.40M 10-Q · filed 2014-11-03 | $7.00M derived: sum of 4 quarters · filed 2014-11-03 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | $1.10M 10-Q · filed 2014-08-01 | $3.70M derived: sum of 3 quarters · filed 2014-08-01 | |
| 2013-03-31 | $1.10M 10-Q · filed 2014-05-08 | $3.70M derived: sum of 2 quarters · filed 2014-05-08 | ||
| 2012-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $4.90M 10-K · filed 2014-02-27 | ||
| 2012-09-30 | $2.30M 10-Q · filed 2013-11-04 | |||
| 2011-12-31 | $3.50M 10-K · filed 2014-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |